Back

Polygenic score for sleep duration in relation to risk of Alzheimer's disease: results from the UK Biobank

Wong, A. T.; Floud, S.; Reeves, G. K.; Holmes, M. V.; Travis, R.; van Duijn, C. M.; Doherty, A.; Smith-Byrne, K.

2022-12-16 epidemiology
10.1101/2022.12.15.22283413 medRxiv
Show abstract

INTRODUCTIONStudies have suggested sleep duration may be associated with Alzheimers disease risk, but findings based on self-reported sleep duration are likely to be influenced by reverse causation and residual confounding bias. METHODSA polygenic score (PGS) for device-measured sleep duration was constructed using LDpred2-auto in 77,770 white British UK Biobank participants. We applied the PGS to 264,746 white British participants independent of the sample from which the PGS was developed. We assessed the association of fifths of genetically predicted sleep duration with Alzheimers disease risk (1,451 cases/264,746 individuals over median 12.5y of follow-up). RESULTSThe PGS explained [~]2% of variation in device-measured sleep duration. Compared to individuals in the middle fifth of PGS, those in the highest fifth (indicating [~]15 mins/day longer sleep) had a lower risk of Alzheimers disease (HR=0.79[95%CI,0.67-0.94]). DISCUSSIONOur results indicate that genetic predisposition to relatively long sleep duration is associated with a lower Alzheimers disease risk.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above